Literature DB >> 8035631

Moyamoya disease: the disorder and surgical treatment.

K Ueki1, F B Meyer, J F Mellinger.   

Abstract

OBJECTIVE: To discuss the clinical features of moyamoya disease, the studies that aid in diagnosing this disorder, and the reported outcomes of surgical treatment.
DESIGN: We review the manifestations of moyamoya disease in children and adults and the recent reports of the various surgical procedures.
MATERIAL AND METHODS: Moyamoya disease is a chronic cerebrovascular disorder in which stenosis of the major arteries of the circle of Willis at the base of the skull progresses to occlusion. The diagnosis is based on the angiographic findings of the "puff of smoke" appearance of the abnormal capillary vessels at the base of the skull. Three surgical procedures are used to manage this disease: anastomosis of the superficial temporal artery to the middle cerebral artery, encephalomyosynangiosis, and encephaloduro-arteriosynangiosis.
RESULTS: In children with this disease, cerebral ischemic events, including strokes, occur. In adults, the fragile abnormal vessels can rupture and cause intracerebral hemorrhage. The mortality rate for adults is higher than that for children. Most published reports support the efficacy of surgical treatment in children but not in adults.
CONCLUSIONS: The natural history of moyamoya disease is poor; neurologic deterioration due to strokes and hemorrhage is progressive. Seizures and intellectual deterioration can occur.

Entities:  

Mesh:

Year:  1994        PMID: 8035631     DOI: 10.1016/s0025-6196(12)61094-5

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  18 in total

1.  Unilateral (probable) moyamoya disease: long-term follow-up of seven cases.

Authors:  Ho Jun Seol; Kyu-Chang Wang; Seung-Ki Kim; Chang Sub Lee; Dong Soo Lee; In-One Kim; Byung-Kyu Cho
Journal:  Childs Nerv Syst       Date:  2005-10-12       Impact factor: 1.475

2.  Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article.

Authors:  Robert M Starke; Ricardo J Komotar; Zachary L Hickman; Yehuda E Paz; Angela G Pugliese; Marc L Otten; Matthew C Garrett; Mitchell S V Elkind; Randolph S Marshall; Joanne R Festa; Philip M Meyers; E Sander Connolly
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

3.  Moyamoya complicated by thrombotic cerebrovascular accident in a Caucasian woman with collagenous colitis.

Authors:  Manshi Valluri; Hossein Akhondi; Mark Hyndman
Journal:  Neurol Sci       Date:  2018-08-09       Impact factor: 3.307

4.  Moyamoya disease - a vasculopahty and an uncommon cause of recurrent cerebrovascular accidents.

Authors:  Yasmin S Hamirani; Mohammad Valikhani; Allison Sweney; Hafsa Khan; Mohammad Pathan
Journal:  J Radiol Case Rep       Date:  2008-09-01

Review 5.  Moyamoya disease.

Authors:  M Farrugia; D C Howlett; A M Saks
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

Review 6.  Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases.

Authors:  S Kawaguchi; T Sakaki; T Morimoto; T Kakizaki; K Kamada
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Clinical features of the haemorrhage type moyamoya disease based on 31 cases.

Authors:  S Kawaguchi; T Sakaki; T Kakizaki; K Kamada; T Shimomura; H Iwanaga
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

8.  New onset focal weakness in children with Down syndrome.

Authors:  Gordon Worley; Rolla Shbarou; Amy N Heffner; Karin M Belsito; George T Capone; Priya S Kishnani
Journal:  Am J Med Genet A       Date:  2004-07-01       Impact factor: 2.802

9.  Psychomotor delay, a possible rare presentation of moyamoya disease.

Authors:  M R Ashrafi; H Alizadeh; S H Yazdani; M Mohseni; M Mohamadi
Journal:  Iran J Radiol       Date:  2011-09-25       Impact factor: 0.212

10.  Multiple burr hole surgery as a treatment modality for pediatric moyamoya disease.

Authors:  Ravindranath Kapu; Nigel Peter Symss; Goutham Cugati; Anil Pande; Chakravarthy M Vasudevan; Ravi Ramamurthi
Journal:  J Pediatr Neurosci       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.